Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Madrigal Pharmaceuticals Inc. (MDGL)

109.04   -4.96 (-4.35%) 01-17 17:03
Open: 112.72 Pre. Close: 114
High: 115.93 Low: 108.605
Volume: 147,739 Market Cap: 1,686M
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The company's lead candidate is MGL-3196, an orally administered, small-molecule, liver-directed, thyroid hormone receptor (THR) ß-selective agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis (NASH). It is also developing MGL-3745, a THR-ß-selective small molecule that is in preclinical trials for the treatment of NASH and hyperlipidemia. The company has research, development, and commercialization agreement with Hoffmann-La Roche to develop, use, sell, offer for sale, and import various licensed products. Madrigal Pharmaceuticals, Inc. was founded in 2011 and is headquartered in West Conshohocken, Pennsylvania.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 116.054 - 116.72 116.72 - 117.321
Low: 107.147 - 107.84 107.84 - 108.466
Close: 108.044 - 109.154 109.154 - 110.155

Technical analysis

as of: 2021-01-15 4:42:57 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 138.46     One year: 148.13
Support: Support1: 105.16    Support2: 87.49
Resistance: Resistance1: 118.55    Resistance2: 126.82
Pivot: 112.44
Moving Average: MA(5): 112.53     MA(20): 113.90
MA(100): 118.39     MA(250): 104.48
MACD: MACD(12,26): -1.87     Signal(9): -1.90
Stochastic oscillator: %K(14,3): 39.26     %D(3): 42.94
RSI: RSI(14): 39.32
52-week: High: 137.28  Low: 56.82  Change(%): 29.9
Average Vol(K): 3-Month: 14342  10-Days: 13066

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
MDGL has closed above bottom band by 22.2%. Bollinger Bands are 20.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 16 Jan 2021
Analysts Anticipate Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Will Post Earnings of -$3.82 Per Share - MarketBeat

Wed, 13 Jan 2021
Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock Rating Lowered by Zacks Investment Research - MarketBeat

Tue, 12 Jan 2021
B.Riley Financial Stick to Their Buy Rating for Madrigal Pharmaceuticals Inc By -

Tue, 05 Jan 2021
Madrigal Pharmaceuticals - Consensus Indicates Potential 43.7% Upside - DirectorsTalk Interviews

Fri, 27 Nov 2020
Madrigal Pharmaceuticals: A Look At The Early MAESTRO Trial Data - Seeking Alpha

Fri, 13 Nov 2020
Madrigal Pharmaceuticals Highlights Presentations at The Liver Meeting Digital Experience™, The American Association for the Study of Liver Diseases Meeting November 13, 2020, Including NASH Expert Insights on the Ongoing Open Label Arm of Resmetirom 52-Week Phase 3 MAESTRO-NAFLD-1 Trial - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 15
Shares Float (M) 7
% Held by Insiders 19.47
% Held by Institutions 93.86
Shares Short (K) 2,440
Shares Short P. Month (K) 2,370

Stock Financials

EPS -11.070
EPS Est This Year -2.670
EPS Est Next Year -3.560
Book Value (p.s.) 18.730
Profit Margin
Operating Margin
Return on Assets (ttm) -27.8
Return on Equity (ttm) -46.8
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -11.421
Qtrly Earnings Growth
Operating Cash Flow (M) -115
Levered Free Cash Flow (M) -57

Stock Valuations

PE Ratio -9.85
PEG Ratio
Price to Book value 5.82
Price to Sales
Price to Cash Flow -14.68

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.